Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1205P (RNA, U6 small nuclear 1205, pseudogene) is classified as a pseudogene in the human genome[4]. Functional U6 small nuclear RNA (U6 snRNA) is highly conserved and essential for the catalytic activity of the spliceosome, which facilitates the removal of introns from pre-mRNA in eukaryotic cells[3][5]. Pseudogenes like RNU6-1205P mimic the structure of the functional U6 snRNA gene but typically do not contribute to spliceosomal RNA pools or regulatory mechanisms[3][4]. There are no experimental data to suggest RNU6-1205P retains any spliceosomal, regulatory, or disease-associated functions, nor is it considered a therapeutic target[4][2].
None known; as there are no interacting drugs, no mechanisms are described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1205, pseudogene (RNU6-1205P).